A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NFATc1

Search Conditions:
Search Keyword : NFATc1
Search Method : Exact match.
Research Area:

Abbreviation: NFATc1
Appearance Frequency: 642 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
nuclear factor of activated T cells c1
(617 times)
(84 times)
RANKL (287 times)
TRAP (173 times)
BMMs (101 times)
2003 Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2.
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
(17 times)
(8 times)
RANKL (12 times)
TRAP (5 times)
BMMs (4 times)
2005 MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
nuclear factor of activated T cells calcineurin-dependent 1
(3 times)
(1 time)
RANKL (2 times)
ERK (1 time)
JmjC (1 time)
2012 JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation.
NF for activation of T cells c1
(1 time)
Allergy and Immunology
(1 time)
AP-1 (1 time)
NF (1 time)
2005 Fos/AP-1 proteins in bone and the immune system.
NFAT cytoplasmic-1
(1 time)
(1 time)
COX-2 (1 time)
CREB (1 time)
NFAT (1 time)
2017 TNFalpha Increases RANKL Expression via PGE₂-Induced Activation of NFATc1.
nuclear factor 1
(1 time)
(1 time)
BC (1 time)
BM (1 time)
MALAT1 (1 time)
2020 Denosumab inhibits MCF-7 cell line-induced spontaneous osteoclastogenesis via the RANKL/MALAT1/miR-124 axis.
nuclear factor calcineurin-dependent 1
(1 time)
Clinical Medicine
(1 time)
RANK (1 time)
2021 A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor.
nuclear factor of T cell c1
(1 time)
(1 time)
OPCs (1 time)
OSCC (1 time)
RANKL (1 time)
2019 A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol.